272 related articles for article (PubMed ID: 24958347)
1. The use of Au@SiO2 shell-isolated nanoparticle-enhanced Raman spectroscopy for human breast cancer detection.
Zheng C; Liang L; Xu S; Zhang H; Hu C; Bi L; Fan Z; Han B; Xu W
Anal Bioanal Chem; 2014 Sep; 406(22):5425-32. PubMed ID: 24958347
[TBL] [Abstract][Full Text] [Related]
2. Exploring type II microcalcifications in benign and premalignant breast lesions by shell-isolated nanoparticle-enhanced Raman spectroscopy (SHINERS).
Liang L; Zheng C; Zhang H; Xu S; Zhang Z; Hu C; Bi L; Fan Z; Han B; Xu W
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Nov; 132():397-402. PubMed ID: 24887501
[TBL] [Abstract][Full Text] [Related]
3. Differences and Relationships Between Normal and Atypical Ductal Hyperplasia, Ductal Carcinoma In Situ, and Invasive Ductal Carcinoma Tissues in the Breast Based on Raman Spectroscopy.
Han B; Du Y; Fu T; Fan Z; Xu S; Hu C; Bi L; Gao T; Zhang H; Xu W
Appl Spectrosc; 2017 Feb; 71(2):300-307. PubMed ID: 28181469
[TBL] [Abstract][Full Text] [Related]
4. Pursuing shell-isolated nanoparticle-enhanced Raman spectroscopy (SHINERS) for concomitant detection of breast lesions and microcalcifications.
Zheng C; Shao W; Paidi SK; Han B; Fu T; Wu D; Bi L; Xu W; Fan Z; Barman I
Nanoscale; 2015 Oct; 7(40):16960-8. PubMed ID: 26415633
[TBL] [Abstract][Full Text] [Related]
5. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.
Xu S; Wei B; Zhang H; Qing M; Bu H
Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952
[TBL] [Abstract][Full Text] [Related]
6. Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ.
Martinez AP; Cohen C; Hanley KZ; Li XB
Arch Pathol Lab Med; 2016 Jul; 140(7):686-9. PubMed ID: 27116088
[TBL] [Abstract][Full Text] [Related]
7. The significance of extracellular mucin in breast fine needle aspiration specimens.
Shield PW; Ribu DL; Cominos D
Cytopathology; 2016 Jun; 27(3):185-92. PubMed ID: 26104545
[TBL] [Abstract][Full Text] [Related]
8. [Role of cytokeratin expression in differential diagnosis of intraductal proliferative lesions of breast].
Zhang JL; Zhang HY; Wei B; Lang ZQ; Bu H
Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):316-9. PubMed ID: 15363314
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy.
Deshaies I; Provencher L; Jacob S; Côté G; Robert J; Desbiens C; Poirier B; Hogue JC; Vachon E; Diorio C
Breast; 2011 Feb; 20(1):50-5. PubMed ID: 20619647
[TBL] [Abstract][Full Text] [Related]
10. Atypia in breast pathology: what pathologists need to know.
Katayama A; Toss MS; Parkin M; Ellis IO; Quinn C; Rakha EA
Pathology; 2022 Feb; 54(1):20-31. PubMed ID: 34872753
[TBL] [Abstract][Full Text] [Related]
11. [Study the Raman spectroscopy of breast tumor limbic tissue].
Zhao YL; Lü J; Ge XH; Yao SX; Liang EJ
Guang Pu Xue Yu Guang Pu Fen Xi; 2006 Jul; 26(7):1267-71. PubMed ID: 17020037
[TBL] [Abstract][Full Text] [Related]
12. Role of deregulated microRNAs in breast cancer progression using FFPE tissue.
Chen L; Li Y; Fu Y; Peng J; Mo MH; Stamatakos M; Teal CB; Brem RF; Stojadinovic A; Grinkemeyer M; McCaffrey TA; Man YG; Fu SW
PLoS One; 2013; 8(1):e54213. PubMed ID: 23372687
[TBL] [Abstract][Full Text] [Related]
13. Recognizing breast ductal carcinoma in situ on fine-needle aspiration: a diagnostic dilemma.
Guo HQ; Zhang ZH; Zhao H; Zhao LL; Pan QJ
Diagn Cytopathol; 2013 Aug; 41(8):710-5. PubMed ID: 23729369
[TBL] [Abstract][Full Text] [Related]
14. Breast carcinogenesis. Transition from hyperplasia to invasive lesions.
Meteoglu I; Dikicioglu E; Erkus M; Culhaci N; Kacar F; Ozkara E; Uyar M
Saudi Med J; 2005 Dec; 26(12):1889-96. PubMed ID: 16380768
[TBL] [Abstract][Full Text] [Related]
15. The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classification.
Pinder SE; Ellis IO
Breast Cancer Res; 2003; 5(5):254-7. PubMed ID: 12927035
[TBL] [Abstract][Full Text] [Related]
16. [Usual hyperplasia, atypical hyperplasia and carcinoma-in-situ of breast: a morphologic study].
Kan X; Shen DH; Shi B; He JS
Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):312-5. PubMed ID: 15363313
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases.
Yeung DK; Yang WT; Tse GM
Radiology; 2002 Oct; 225(1):190-7. PubMed ID: 12355004
[TBL] [Abstract][Full Text] [Related]
18. Atypical ductal hyperplasia is a multipotent precursor of breast carcinoma.
Kader T; Hill P; Zethoven M; Goode DL; Elder K; Thio N; Doyle M; Semple T; Sufyan W; Byrne DJ; Pang JB; Murugasu A; Miligy IM; Green AR; Rakha EA; Fox SB; Mann GB; Campbell IG; Gorringe KL
J Pathol; 2019 Jul; 248(3):326-338. PubMed ID: 30843206
[TBL] [Abstract][Full Text] [Related]
19. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
Piubello Q; Montemezzi S; D'Atri C
Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
[TBL] [Abstract][Full Text] [Related]
20. Atypical Ductal Hyperplasia Bordering on Ductal Carcinoma In Situ.
Tozbikian G; Brogi E; Vallejo CE; Giri D; Murray M; Catalano J; Olcese C; Van Zee KJ; Wen HY
Int J Surg Pathol; 2017 Apr; 25(2):100-107. PubMed ID: 27481892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]